Showing all 3 results
Neostigmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic bromide salt.
Active Ingredient Strength Primary Clinical Function Neostigmine Bromide Ph.Eur./USP 15 mg Global Clinical Standard: Base therapeutic oral unit for the continuous, meticulously spaced symptomatic management of Myasthenia Gravis. Excipients Lactose Monohydrate / Maize Starch / Povidone K30 / Talc / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered specifically for rapid, predictable gastric dissolution to ensure precise symptom control within 30 to 45 minutes of ingestion) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic neurology dispensing, as patients may require up to 10-15 tablets per day in divided doses).
Tamsulosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Dutasteride USP/Ph.Eur. 0.5 mg Dual 5-alpha-reductase inhibition for profound DHT suppression and prostate volume reduction. Excipients Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Microcrystalline Cellulose / Magnesium Stearate SR Polymer matrix for Tamsulosin / Antioxidant stabilizer for solid-state Dutasteride (Engineered for strict segregation) Tamsulosin & Finasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant and child-resistant Alu-Alu blister strips to ensure the absolute stability of both the kinetic polymer matrix and the sensitive hormonal API.
Active Ingredient Strength Primary Clinical Function Tamsulosin Hydrochloride USP/Ph.Eur. 0.4 mg (Modified-Release) Continuous 24-hour uro-selective alpha-1A blockade for immediate symptom relief. Finasteride USP/Ph.Eur. 5 mg Targeted Type II 5-alpha-reductase inhibition for profound DHT suppression and prostate shrinkage. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate SR Polymer matrix for Tamsulosin / Diluent for Finasteride (Engineered for strict kinetic segregation)
